← Open Payments lookup

TRAVIS WEISZHAAR: Open Payments

NPI 1962585752 · REXBURG, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$294 in 15 payments from 11 companies in 2025. Trend: 2023 $366 · 2024 $199 · 2025 $294

Food & beverage: $294
CompanyPaymentsAmount
Insulet Corporation2$58
Axsome Therapeutics, Inc.2$48
Lilly USA, LLC2$35
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$35
Supernus Pharmaceuticals, Inc.1$21
Merck Sharp & Dohme LLC1$20
Medtronic, Inc.1$19
Amgen Inc.1$16
AstraZeneca Pharmaceuticals LP1$15
Novo Nordisk Inc1$14

Products named: Omnipod, Auvelity, MOUNJARO, CAPLYTA, Qelbree, ROTATEQ, INTERSTIM, OTEZLA.

Industry payments across ID — which companies pay providers there.